Intravenous and intranasal heroin-dependent treatment-seekers: Characteristics and treatment outcome

Addiction

Volumn 102, Issue 11, 2007, Pages 1816-1823

  Highfield, David A ^a   Schwartz, Robert P ^a   Jaffe, Jerome H ^a   O'Grady, Kevin E ^b  

^a FRIENDS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Heroin; Injection; Intranasal; Intravenous; Methadone; Snorting

Indexed keywords

METHADONE;

ADULT; ARTICLE; COMPARATIVE STUDY; CRIMINAL BEHAVIOR; DISEASE SEVERITY; FEMALE; HEROIN DEPENDENCE; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RISK ASSESSMENT; TREATMENT OUTCOME; URINALYSIS;

ADULT; COCAINE-RELATED DISORDERS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEROIN; HEROIN DEPENDENCE; HUMANS; MALE; MARYLAND; METHADONE; PATIENT ACCEPTANCE OF HEALTH CARE; SOCIAL CLASS; SUBSTANCE ABUSE TREATMENT CENTERS; TREATMENT OUTCOME;

EID: 35348882617     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2007.01998.x     Document Type: Article

References (31)

1. Celentano D., Munoz A., Cohn S., Vlahov D. Dynamics of behavioral risk factors for HIV/AIDS: a 6-year prospective study on injection drug users. Drug Alcohol Depend 2001 61:315 22.
2. Friedman S., Flom P., Kottiri B., Zenilman J., Curtis R., Neaigus A. et al. Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City. Addiction 2003 98:159 69.
3. Vlahov D., Lee H., Taylor E., Canavaggio M., Canner C., Burczak J. et al. Antibody to human T-lymphotropic virus type I/II HT LV-I/II among male inmates entering Maryland prisons. J Acquir Immune Defic Syndr 1990 3:531 5.
4. Darke S., Hetherington K., Ross J., Lynskey M., Teesson M. Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence. Drug Alcohol Rev 2004 23:177 83.
5. Strang J., Griffiths P., Powis B., Gossop M. Heroin chasers and heroin injectors: differences observed in a community sample in London, UK. Am J Addict 1999 8:148 60.
6. Office of Applied Studies/Substance Abuse and Mental Health Services Administration (SAMHSA). The DASIS Report: Characteristics of Primary Heroin Injection and Inhalation Admissions: 2002. Rockville, MD:SAMHSA. Available from http://oas.samhsa.gov/2k4/heroin/heroin.cfm (accessed 21 August 2007).
7. Des Jarlais D. C., Arasteh K., Perlis T., Hagan H., Abdul-Quader A., Heckathorn D. D. et al. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS 2007 21:231 5.
8. Carpenter M., Chutuape M., Stitzer M. Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples. Drug Alcohol Depend 1998 53:11 15.
9. Latkin C., Knowlton A., Sherman S. Routes of drug administration, differential affiliation, and lifestyle stability among cocaine and opiate users: implications to HIV prevention. J Subst Abuse 2001 13:89 102.
10. Griffiths P., Gossop M., Powis B., Strang J. Extent and nature of transitions of route among heroin addicts in treatment - preliminary data from the drug transitions study. Br J Addict 1992 87:485 91.
11. Strang J., Griffiths P., Powis B., Abbey J., Gossop M. How constant is an individuals route of heroin administration? Data from treatment and non-treatment samples. Drug Alcohol Depend 1997 46:115 18.
12. Office of Applied Studies/Substance Abuse and Mental Health Services Administration (SAMHSA). The DASIS Report: Heroin - Changes in How it is Used: 1992-2002. Rockville, MD:SAMHSA. Available from http://oas.samhsa.gov/2k4/ HeroinTrends/HeroinTrends.cfm (accessed 21 August 2007).
13. Neaigus A., Miller M., Friedman S., Hagen D., Sifaneck S., Ildefonso G. et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction 2001 96:847 60.
14. National Research Council. Informing America's policy on illegal drugs: what we don't know keeps hurting us. Committee on data and research for policy on illegal drugs. In:Manski C.F., Pepper J.V., Petric C.V., editors. Committee on Law and Justice and Committee on National Statistics. Commission on Behavioral and Social Sciences and Education. Washington, DC:National Academy Press 2001, p. 137 86.
15. Schwartz R. P., Highfield D. A., Jaffe J. H., Butler C. B., Rouse C. O., Callaman J. et al. A randomized controlled trial of interim methadone maintenance. Arch Gen Psychiatry 2006 63:102 9.
16. McLellan A. T., Luborsky L., Woody G. E., O'Brien C. P. An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis 1980 168:26 33.
17. McLellan A. T., Luborsky L., Cacciola J. S., Griffin J., Evans F., Barr H. L. et al. New data from the ASI, reliability and validity in three centers. J Nerv Ment Dis 1985 173:412 23.
18. McLellan A. T., Kushner H., Metzger D., Peters R., Smith I., Grissom G. et al. The fifth edition of the Addiction Severity Index: historical critique and normative data. J Subst Abuse Treat 1992 9:199 213.
19. Schwartz R. P., Jaffe J. H., Highfield D. A., Callaman J., O'Grady K. E. A randomized controlled trial of interim methadone maintenance: 10-month follow-up. Drug Alcohol Depend 2007 86:30 6.
20. Simpson D., Knight K., Ray S. Psychosocial correlates of AIDS-risk drug use and sexual behaviors. AIDS Educ Prev 1993 5:121 30.
21. Nurco D. N., Hanlon T. E., Kinlock T. W., Duszynski K. R. Differential criminal patterns of narcotic addicts over an addiction career. Criminology 1988 26:407 23.
22. Kinlock T. W., O'Grady K. E., Hanlon T. E. Prediction of the criminal activity of incarcerated drug-abusing offenders. J Drug Issues 2003 33:897 920.
23. Barrio G., De La Fuente L., Lew C., Royuela L., Bravo M., Torrens M. Differences in severity of heroin dependence by route of administration: the importance of length of heroin use. Drug Alcohol Depend 2001 63:169 77.
24. Gossop M., Stewart D., Marsden J., Kidd T., Strang J. Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment. Addict Behav 2004 29:1085 94.
25. Darke S., Ross J., Teesson M. Twelve-month outcomes for heroin dependence treatments: does route of administration matter? Drug Alcohol Rev 2005 24:165 71.
26. Neaigus A., Gyarmathy V. A., Miller M., Frajzyngier V. M., Friedman S. R., Des Jarlais D. C. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr 2006 41:493 503.
27. Slotheran J., Goldsmith D., Blasco M., Friedman S. Heroin sniffing as self-regulation among injecting and non-injecting heroin users. J Drug Issues 1999 29:401 22.
28. Fuller C., Vlahov D., Arria A., Ompad D., Garfein R., Strathdee S. Factors associated with adolescent initiation of injection drug use. Public Health Rep Suppl 2001 116:136 45.
29. Schottenfeld R., O'Malley S., Abdul-Salaam K., O'Connor P. Decline in intravenous drug use among treatment-seeking opiate users. J Subst Abuse Treat 1993 10:5 10.
30. Barnett P. The cost-effectiveness of methadone maintenance as a health care intervention. Addiction 1999 94:479 88.
31. Mark T., Woody G., Juday T., Kleber H. The economic costs of heroin addiction in the United States. Drug Alcohol Depend 2001 61:195 206.